Walleye Capital’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$374K Buy
+34,100
New +$404K ﹤0.01% 4324

Other funds holding ZVRA

Walleye Capital's ZVRA Position: Q3 2026 in Review

Walleye Capital opened a new position in Zevra Therapeutics (ZVRA) in Q3 2026: 34,100 shares worth $374K. The stake represents ﹤0.01% of the portfolio and ranks #4324 among its holdings.

174 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Walleye Capital held 34,100 shares of Zevra Therapeutics worth $374K as of Q3 2026.
  • Zevra Therapeutics was a new Walleye Capital position in Q3 2026.
  • Zevra Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4324 holding.
  • 174 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.